685105-96-8

Usage

Chemical class

Piperazine derivatives

Common use

Pharmaceutical intermediate and research chemical

Physical appearance

White to off-white crystalline powder

Solubility

Soluble in water

Molecular weight

240.35 g/mol

Potential applications

Treatment of neurological disorders and mood-related disorders

Safety considerations

Handle with care and follow proper safety protocols due to potential hazards if not used properly

InChI:InChI=1/C12H18N2.2ClH/c1-11(12-5-3-2-4-6-12)14-9-7-13-8-10-14;;/h2-6,11,13H,7-10H2,1H3;2*1H/t11-;;/m0../s1

Upstream product

• 98-86-2 acetophenone 
• 585-71-7 (1-bromoethyl)benzne 
• 98-85-1 1-Phenylethanol 
• 773848-51-4 1-[(R)-1-phenylethyl]piperazine 
• 685105-90-2 (R)-4-(1-phenylethyl)-piperazine-2,6-dione 

Relevant academic research and scientific papers

TRICYCLIC COMPOUNDS

Provided herein are compounds and pharmaceutical compositions comprising said compounds that are useful for treating cancers or congenital diseases. Specific cancers and congenital disease includes those that are mediated by YAP/TAZ.

Pyruvate kinase activators for use in therapy

Described herein are methods for using compounds that activate pyruvate kinase.

5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF

Compounds of Formula (00A) and methods of use as Janus kinase inhibitors are described herein.

Aralkyl-ketone piperazine derivatives and their uses as new antalgic or ataractic agent

Arylalkyl ketone piperazine derivatives of the formula: and pharmaceutical compositions comprising the same. Also dislcosed are methods for using the compounds as analgesic and sedative agents. The compounds of the present invention have good analgesic and sedative activities but few side effects.

Aralkyl-alcohol peiperazine derivatives adn their uses as antidepressant

Aryl alkanol piperazine derivatives of the formula and pharmaceutical compositions comprising the same. Also disclosed are methods for treating depression using the pharmaceutical compositon. Compounds of the invention have excellent dual inhibitory actions to the uptake of the mono-amines neurotransmitter, good antidepressant activities and minor side effects.